{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:52:33Z","timestamp":1785840753943,"version":"3.56.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Gazi University Scientific Research Projects Coordination Unit","award":["TDK-2025-10053"],"award-info":[{"award-number":["TDK-2025-10053"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12531-1","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:36:14Z","timestamp":1785839774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Downregulation of circulating miR-22 and elevation of serum ATP-citrate lyase in colorectal cancer: a proof-of-concept study"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8968-647X","authenticated-orcid":false,"given":"Nazila","family":"Sahraei Danalou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9150-9499","authenticated-orcid":false,"given":"Kursat","family":"Dikmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5129-2515","authenticated-orcid":false,"given":"Ece","family":"Konac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5916-2675","authenticated-orcid":false,"given":"Orhan","family":"Canbolat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5135-8067","authenticated-orcid":false,"given":"Mustafa","family":"Kavutcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"12531_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics, 2021. CA Cancer J Clin 71:7\u201333. https:\/\/doi.org\/10.3322\/caac.21654","journal-title":"CA Cancer J Clin"},{"key":"12531_CR2","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/S0140-6736(13)61649-9","volume":"383","author":"H Brenner","year":"2014","unstructured":"Brenner H, Kloor M, Pox CP (2014) Colorectal cancer. Lancet 383:1490\u20131502. https:\/\/doi.org\/10.1016\/S0140-6736(13)61649-9","journal-title":"Lancet"},{"key":"12531_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"12531_CR4","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold M, Sierra MS, Laversanne M et al (2017) Global patterns and trends in colorectal cancer incidence and mortality. Gut 66:683\u2013691. https:\/\/doi.org\/10.1136\/gutjnl-2015-310912","journal-title":"Gut"},{"key":"12531_CR5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"12531_CR6","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrc2222","volume":"7","author":"JA Menendez","year":"2007","unstructured":"Menendez JA, Lupu R (2007) Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7:763\u2013777. https:\/\/doi.org\/10.1038\/nrc2222","journal-title":"Nat Rev Cancer"},{"key":"12531_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ccr.2005.09.008","volume":"8","author":"G Hatzivassiliou","year":"2005","unstructured":"Hatzivassiliou G, Zhao F, Bauer DE et al (2005) ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8:311\u2013321. https:\/\/doi.org\/10.1016\/j.ccr.2005.09.008","journal-title":"Cancer Cell"},{"key":"12531_CR8","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1126\/science.1164097","volume":"324","author":"KE Wellen","year":"2009","unstructured":"Wellen KE, Hatzivassiliou G, Sachdeva UM et al (2009) ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324:1076\u20131080. https:\/\/doi.org\/10.1126\/science.1164097","journal-title":"Science"},{"key":"12531_CR9","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1158\/0008-5472.CAN-11-4112","volume":"72","author":"N Zaidi","year":"2012","unstructured":"Zaidi N, Swinnen JV, Smans K (2012) ATP-citrate lyase: a key player in cancer metabolism. Cancer Res 72:3709\u20133714. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-4112","journal-title":"Cancer Res"},{"key":"12531_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281\u2013297. https:\/\/doi.org\/10.1016\/S0092-8674(04)00045-5","journal-title":"Cell"},{"key":"12531_CR11","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1111\/j.1742-4658.2010.07594.x","volume":"277","author":"J Xiong","year":"2010","unstructured":"Xiong J, Yu D, Wei N et al (2010) An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. FEBS J 277:1684\u20131694. https:\/\/doi.org\/10.1111\/j.1742-4658.2010.07594.x","journal-title":"FEBS J"},{"key":"12531_CR12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cell.2013.06.026","volume":"154","author":"SJ Song","year":"2013","unstructured":"Song SJ, Poliseno L, Song MS et al (2013) MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell 154:311\u2013324. https:\/\/doi.org\/10.1016\/j.cell.2013.06.026","journal-title":"Cell"},{"key":"12531_CR13","doi-asserted-by":"publisher","first-page":"36266","DOI":"10.18632\/oncotarget.16742","volume":"8","author":"S-S Xia","year":"2017","unstructured":"Xia S-S, Zhang G-J, Liu Z-L et al (2017) MicroRNA-22 suppresses the growth, migration and invasion of colorectal cancer cells through a Sp1 negative feedback loop. Oncotarget 8:36266\u201336278. https:\/\/doi.org\/10.18632\/oncotarget.16742","journal-title":"Oncotarget"},{"key":"12531_CR14","doi-asserted-by":"publisher","first-page":"44252","DOI":"10.18632\/oncotarget.10020","volume":"7","author":"M Xin","year":"2016","unstructured":"Xin M, Qiao Z, Li J et al (2016) miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer. Oncotarget 7:44252\u201344265. https:\/\/doi.org\/10.18632\/oncotarget.10020","journal-title":"Oncotarget"},{"key":"12531_CR15","doi-asserted-by":"publisher","first-page":"e83025","DOI":"10.1371\/journal.pone.0083025","volume":"8","author":"G Zheng","year":"2013","unstructured":"Zheng G, Wang H, Zhang X et al (2013) Identification and validation of reference genes for qPCR detection of serum microRNAs in colorectal adenocarcinoma patients. PLoS ONE 8:e83025. https:\/\/doi.org\/10.1371\/journal.pone.0083025","journal-title":"PLoS ONE"},{"key":"12531_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"key":"12531_CR17","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1093\/nar\/30.9.e36","volume":"30","author":"MW Pfaffl","year":"2002","unstructured":"Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:e36. https:\/\/doi.org\/10.1093\/nar\/30.9.e36","journal-title":"Nucleic Acids Res"},{"key":"12531_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.28092\/j.issn.2095-3941.2015.0103","volume":"13","author":"K Tariq","year":"2016","unstructured":"Tariq K, Ghias K (2016) Colorectal cancer carcinogenesis: a review of mechanisms. Cancer Biol Med 13:120\u2013135. https:\/\/doi.org\/10.28092\/j.issn.2095-3941.2015.0103","journal-title":"Cancer Biol Med"},{"key":"12531_CR19","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3390\/jpm12081329","volume":"12","author":"N Suriya Muthukumaran","year":"2022","unstructured":"Suriya Muthukumaran N, Velusamy P, Akino Mercy CS et al (2022) MicroRNAs as regulators of cancer cell energy metabolism. J Pers Med 12:1329. https:\/\/doi.org\/10.3390\/jpm12081329","journal-title":"J Pers Med"},{"key":"12531_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3892\/ijo.2016.3811","volume":"50","author":"J Wang","year":"2017","unstructured":"Wang J, Li Y, Ding M et al (2017) Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (review). Int J Oncol 50:345\u2013355. https:\/\/doi.org\/10.3892\/ijo.2016.3811","journal-title":"Int J Oncol"},{"key":"12531_CR21","doi-asserted-by":"publisher","first-page":"147955","DOI":"10.1016\/j.gene.2023.147955","volume":"894","author":"G Li","year":"2024","unstructured":"Li G, Zhao D, Peng X, Zhao Y (2024) Expression of miR-22 profiling in colorectal normal-adenoma-carcinoma sequence. Gene 894:147955. https:\/\/doi.org\/10.1016\/j.gene.2023.147955","journal-title":"Gene"},{"key":"12531_CR22","doi-asserted-by":"publisher","first-page":"4628","DOI":"10.1158\/0008-5472.CAN-10-2475","volume":"71","author":"N Tsuchiya","year":"2011","unstructured":"Tsuchiya N, Izumiya M, Ogata-Kawata H et al (2011) Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21. Cancer Res 71:4628\u20134639. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2475","journal-title":"Cancer Res"},{"key":"12531_CR23","doi-asserted-by":"publisher","first-page":"5419","DOI":"10.2147\/CMAR.S255125","volume":"12","author":"J Cong","year":"2020","unstructured":"Cong J, Gong J, Yang C et al (2020) miR-22 suppresses tumor invasion and metastasis in colorectal cancer by targeting NLRP3. Cancer Manag Res 12:5419\u20135429. https:\/\/doi.org\/10.2147\/CMAR.S255125","journal-title":"Cancer Manag Res"},{"key":"12531_CR24","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1007\/s12032-012-0233-9","volume":"29","author":"G Zhang","year":"2012","unstructured":"Zhang G, Xia S, Tian H et al (2012) Clinical significance of miR-22 expression in patients with colorectal cancer. Med Oncol 29:3108\u20133112. https:\/\/doi.org\/10.1007\/s12032-012-0233-9","journal-title":"Med Oncol"},{"key":"12531_CR25","doi-asserted-by":"publisher","first-page":"e20291","DOI":"10.1371\/journal.pone.0020291","volume":"6","author":"M Yamakuchi","year":"2011","unstructured":"Yamakuchi M, Yagi S, Ito T, Lowenstein CJ (2011) MicroRNA-22 regulates hypoxia signaling in colon cancer cells. PLoS ONE 6:e20291. https:\/\/doi.org\/10.1371\/journal.pone.0020291","journal-title":"PLoS ONE"},{"key":"12531_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.canlet.2019.12.010","volume":"471","author":"P Icard","year":"2020","unstructured":"Icard P, Wu Z, Fournel L et al (2020) ATP citrate lyase: a central metabolic enzyme in cancer. Cancer Lett 471:125\u2013134. https:\/\/doi.org\/10.1016\/j.canlet.2019.12.010","journal-title":"Cancer Lett"},{"key":"12531_CR27","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.3390\/biom11101531","volume":"11","author":"Z Gaal","year":"2021","unstructured":"Gaal Z (2021) MicroRNAs and metabolism: revisiting the Warburg effect with emphasis on epigenetic background and clinical applications. Biomolecules 11:1531. https:\/\/doi.org\/10.3390\/biom11101531","journal-title":"Biomolecules"},{"key":"12531_CR28","doi-asserted-by":"publisher","first-page":"8547","DOI":"10.1158\/0008-5472.CAN-08-1235","volume":"68","author":"T Migita","year":"2008","unstructured":"Migita T, Narita T, Nomura K et al (2008) ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. Cancer Res 68:8547\u20138554. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-1235","journal-title":"Cancer Res"},{"key":"12531_CR29","first-page":"7855","volume":"8","author":"X Qian","year":"2015","unstructured":"Qian X, Hu J, Zhao J, Chen H (2015) ATP citrate lyase expression is associated with advanced stage and prognosis in gastric adenocarcinoma. Int J Clin Exp Med 8:7855\u20137860","journal-title":"Int J Clin Exp Med"},{"key":"12531_CR30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2174\/1389450115666141224125117","volume":"16","author":"AD Khwairakpam","year":"2015","unstructured":"Khwairakpam AD, Shyamananda MS, Sailo BL et al (2015) ATP citrate lyase (ACLY): a promising target for cancer prevention and treatment. Curr Drug Targets 16:156\u2013163. https:\/\/doi.org\/10.2174\/1389450115666141224125117","journal-title":"Curr Drug Targets"},{"key":"12531_CR31","doi-asserted-by":"publisher","first-page":"144963","DOI":"10.1016\/j.gene.2020.144963","volume":"758","author":"V Gurbuz","year":"2020","unstructured":"Gurbuz V, Kiliccioglu I, Dikmen AU et al (2020) Comparative analysis of epi-miRNA expression levels in local\/locally advanced and metastatic prostate cancer patients. Gene 758:144963. https:\/\/doi.org\/10.1016\/j.gene.2020.144963","journal-title":"Gene"},{"key":"12531_CR32","first-page":"659","volume":"10","author":"H Liu","year":"2018","unstructured":"Liu H, Huang X, Ye T (2018) MiR-22 down-regulates the proto-oncogene ATP citrate lyase to inhibit the growth and metastasis of breast cancer. Am J Transl Res 10:659\u2013669","journal-title":"Am J Transl Res"},{"key":"12531_CR33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s13046-019-1391-9","volume":"38","author":"J Wen","year":"2019","unstructured":"Wen J, Min X, Shen M et al (2019) ACLY facilitates colon cancer cell metastasis by CTNNB1. J Exp Clin Cancer Res 38:401. https:\/\/doi.org\/10.1186\/s13046-019-1391-9","journal-title":"J Exp Clin Cancer Res"},{"key":"12531_CR34","doi-asserted-by":"publisher","first-page":"e0281536","DOI":"10.1371\/journal.pone.0281536","volume":"18","author":"S Cui","year":"2023","unstructured":"Cui S, Chen Y, Guo Y et al (2023) Hsa-miR-22-3p inhibits liver cancer cell EMT and cell migration\/invasion by indirectly regulating SPRY2. PLoS ONE 18:e0281536. https:\/\/doi.org\/10.1371\/journal.pone.0281536","journal-title":"PLoS ONE"},{"key":"12531_CR35","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.3892\/or.2013.2300","volume":"29","author":"B Li","year":"2013","unstructured":"Li B, Song Y, Liu TJ et al (2013) miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9. Oncol Rep 29:1946\u20131954. https:\/\/doi.org\/10.3892\/or.2013.2300","journal-title":"Oncol Rep"},{"key":"12531_CR36","doi-asserted-by":"publisher","first-page":"e2000","DOI":"10.1038\/cddis.2015.297","volume":"6","author":"QF Zuo","year":"2015","unstructured":"Zuo QF, Cao LY, Yu T et al (2015) MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail. Cell Death Dis 6:e2000. https:\/\/doi.org\/10.1038\/cddis.2015.297","journal-title":"Cell Death Dis"},{"key":"12531_CR37","doi-asserted-by":"publisher","first-page":"e0126357","DOI":"10.1371\/journal.pone.0126357","volume":"10","author":"A Csanadi","year":"2015","unstructured":"Csanadi A, Kayser C, Donauer M et al (2015) Prognostic value of malic enzyme and ATP-citrate lyase in non-small cell lung cancer of the young and the elderly. PLoS ONE 10:e0126357. https:\/\/doi.org\/10.1371\/journal.pone.0126357","journal-title":"PLoS ONE"},{"key":"12531_CR38","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1158\/1535-7163.MCT-13-0098","volume":"12","author":"Y Zhou","year":"2013","unstructured":"Zhou Y, Bollu LR, Tozzi F et al (2013) ATP citrate lyase mediates resistance of colorectal cancer cells to SN38. Mol Cancer Ther 12:2782\u20132791. https:\/\/doi.org\/10.1158\/1535-7163.MCT-13-0098","journal-title":"Mol Cancer Ther"},{"key":"12531_CR39","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cmet.2014.06.004","volume":"20","author":"JV Lee","year":"2014","unstructured":"Lee JV, Carrer A, Shah S et al (2014) Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metab 20:306\u2013319. https:\/\/doi.org\/10.1016\/j.cmet.2014.06.004","journal-title":"Cell Metab"},{"key":"12531_CR40","doi-asserted-by":"publisher","first-page":"13457","DOI":"10.1038\/ncomms13457","volume":"7","author":"SL Pinkosky","year":"2016","unstructured":"Pinkosky SL, Newton RS, Day EA et al (2016) Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis. Nat Commun 7:13457. https:\/\/doi.org\/10.1038\/ncomms13457","journal-title":"Nat Commun"},{"key":"12531_CR41","doi-asserted-by":"publisher","first-page":"e696","DOI":"10.1038\/cddis.2013.215","volume":"4","author":"JI Hanai","year":"2013","unstructured":"Hanai JI, Doro N, Seth P, Sukhatme VP (2013) ATP citrate lyase knockdown impacts cancer stem cells in vitro. Cell Death Dis 4:e696. https:\/\/doi.org\/10.1038\/cddis.2013.215","journal-title":"Cell Death Dis"},{"key":"12531_CR42","doi-asserted-by":"publisher","first-page":"106933","DOI":"10.1016\/j.bioorg.2023.106933","volume":"142","author":"JJ Liang","year":"2024","unstructured":"Liang JJ, Zhou XF, Long H et al (2024) Recent advance of ATP citrate lyase inhibitors for the treatment of cancer and related diseases. Bioorg Chem 142:106933. https:\/\/doi.org\/10.1016\/j.bioorg.2023.106933","journal-title":"Bioorg Chem"},{"key":"12531_CR43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.stem.2013.06.003","volume":"13","author":"SJ Song","year":"2013","unstructured":"Song SJ, Ito K, Ala U et al (2013) The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell 13:87\u2013101. https:\/\/doi.org\/10.1016\/j.stem.2013.06.003","journal-title":"Cell Stem Cell"},{"key":"12531_CR44","doi-asserted-by":"publisher","first-page":"11452","DOI":"10.1038\/ncomms11452","volume":"7","author":"X Jiang","year":"2016","unstructured":"Jiang X, Hu C, Arnovitz S et al (2016) miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia. Nat Commun 7:11452. https:\/\/doi.org\/10.1038\/ncomms11452","journal-title":"Nat Commun"},{"key":"12531_CR45","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1136\/gut.2008.167817","volume":"58","author":"EKO Ng","year":"2009","unstructured":"Ng EKO, Chong WWS, Jin H et al (2009) Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58:1375\u20131381. https:\/\/doi.org\/10.1136\/gut.2008.167817","journal-title":"Gut"},{"key":"12531_CR46","doi-asserted-by":"publisher","first-page":"1603032","DOI":"10.3389\/fimmu.2025.1603032","volume":"16","author":"W Liu","year":"2025","unstructured":"Liu W, Dong S, Hao F et al (2025) Lipid metabolic reprogramming in colorectal cancer: mechanisms and therapeutic strategies. Front Immunol 16:1603032. https:\/\/doi.org\/10.3389\/fimmu.2025.1603032","journal-title":"Front Immunol"},{"key":"12531_CR47","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3390\/ijms26020782","volume":"26","author":"S Tomasini","year":"2025","unstructured":"Tomasini S, Vigo P, Margiotta F et al (2025) The role of microRNA-22 in metabolism. Int J Mol Sci 26:782. https:\/\/doi.org\/10.3390\/ijms26020782","journal-title":"Int J Mol Sci"},{"key":"12531_CR48","doi-asserted-by":"publisher","first-page":"1574586","DOI":"10.3389\/fgene.2025.1574586","volume":"16","author":"S Schwab","year":"2025","unstructured":"Schwab S, Nonaka T (2025) Circulating miRNAs as liquid biopsy biomarkers for diagnosis in patients with colorectal cancer: a systematic review and meta-analysis. Front Genet 16:1574586. https:\/\/doi.org\/10.3389\/fgene.2025.1574586","journal-title":"Front Genet"},{"key":"12531_CR49","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1631\/jzus.B0920077","volume":"10","author":"QL Liang","year":"2009","unstructured":"Liang QL, Wang BR, Li GH (2009) DcR3 and survivin are highly expressed in colorectal carcinoma and closely correlated to its clinicopathologic parameters. J Zhejiang Univ Sci B 10:675\u2013682. https:\/\/doi.org\/10.1631\/jzus.B0920077","journal-title":"J Zhejiang Univ Sci B"},{"key":"12531_CR50","doi-asserted-by":"publisher","first-page":"878639","DOI":"10.3389\/fonc.2022.878639","volume":"12","author":"XC Hong","year":"2022","unstructured":"Hong XC, Liang QL, Chen M et al (2022) PRL-3 and MMP9 expression and epithelial-mesenchymal transition markers in circulating tumor cells from patients with colorectal cancer: potential value in clinical practice. Front Oncol 12:878639. https:\/\/doi.org\/10.3389\/fonc.2022.878639","journal-title":"Front Oncol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12531-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12531-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12531-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:36:16Z","timestamp":1785839776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12531-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12531"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12531-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"6 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Gazi University Clinical Research Ethics Committee (Date: November 25, 2024; Decision No: 09).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. The manuscript contains no data or images from which an individual participant could be identified.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1339"}}